Ashwani Kumar

Employment

• Yale University Associate Research Scientist
  2024 - Present
• Yale University Postdoctoral Associate
  2023 - 2024
• Postgraduate Institute of Medical Education and Research, Chandigarh Senior Demonstrator
  2021 - 2023
• Post Graduate Institute of Medical Education and Research Postdoctoral Research Fellow
  2018 - 2021
• Post Graduate Institute of Medical Education and Research PhD Scholar
  2012 - 2017
• Post Graduate Institute of Medical Education and Research Senior Research Fellow
  2009 - 2012

Education

• Post Graduate Institute of Medical Education and Research Ph.D.
  2012 - 2017
• Hemwati Nandan Bahuguna Garhwal University Master of Science
  2004 - 2006
• Himachal Pradesh University B. Ed (Teaching of Life sciences)
  2003 - 2004
• Himachal Pradesh University Bachelor of Science
  2000 - 2003

Projects & Funding

Projects & funding information is unavailable.

Publications (68)

• Quantifying donor-recipient mismatches using recipient-derived sources of donor DNA
  Medrxiv 2026 DOI: 10.64898/2026.06.01.26354606
  +Save
• APOL1 risk alleles modulate T cell receptor signaling to promote allograft rejection
  Journal of Clinical Investigation 2026 DOI: 10.1172/JCI193173
  +Save
• Design of precision therapeutics for a CKD risk allele by targeting Shroom3-Rock interaction
  Nature Communications 2025 DOI: 10.1038/s41467-025-67854-7
  +Save
• Design and development of a urinary cell pellet mRNA PCR-based assay for progressive kidney disease: Nephro-Dx
  2025 DOI: 10.1101/2025.10.31.25338655
  +Save
• LILRB3 genetic variation is associated with kidney transplant failure in African American recipients
  Nature Medicine 2025 DOI: 10.1038/S41591-025-03568-Z
  +Save
• A T-cell intrinsic Role for APOL1 Risk Alleles in Allograft Rejection
  Biorxiv 2025 DOI: 10.1101/2025.07.14.664793
  +Save
• Author Correction: LILRB3 genetic variation is associated with kidney transplant failure in African American recipients (Nature Medicine, (2025), 31, 5, (1677-1687), 10.1038/s41591-025-03568-z)
  Nature Medicine 2025 DOI: 10.1038/s41591-025-03706-7
  +Save
• Vincristine in FSGS Rediscovering an Old Therapeutic for FSGS
  KIDNEY INTERNATIONAL REPORTS 2025 DOI: 10.1016/J.EKIR.2025.09.018
  +Save
• Shroom3-Rock interaction and profibrotic function: Resolving mechanism of an intronic CKD risk allele
  2024 DOI: 10.1101/2024.11.22.624409
  +Save
• Rationale and Design of a Phase 2 Double-blind, Placebo-Controlled , , Randomized Trial Evaluating AMP Kinase-Activation by Metformin in Focal Segmental Glomerulosclerosis
  Kidney International Reports 2024 DOI: 10.1016/J.EKIR.2024.02.006
  +Save